Antiplatelet therapy and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage:...

KS Lee, C Lee, PS Dhillon, R Kirollos, VDW Nga… - Neurosurgical …, 2023 - Springer

Antiplatelet therapy (AT) may serve to reduce the effects of aneurysmal subarachnoid
hemorrhage (aSAH)-induced pro-coagulant state in the cerebral circulation. Several studies …

被引用次数：10 相关文章所有 6 个版本

Microclots in subarachnoid hemorrhage: an underestimated factor in delayed cerebral ischemia?

M Monsour, DM Croci, S Agazzi - Clinical Neurology and Neurosurgery, 2022 - Elsevier

Subarachnoid hemorrhage has a poor prognosis due to the wide array of associated
complications such as vasospasm, early brain injury, cortical spreading depression …

被引用次数：7 相关文章所有 3 个版本

[PDF] ahajournals.org Full View

Intraarterial nimodipine versus induced hypertension for delayed cerebral ischemia: a modified treatment protocol

M Weiss, W Albanna, C Conzen-Dilger, N Kastenholz… - Stroke, 2022 - Am Heart Assoc

Background: Rescue treatment for delayed cerebral ischemia (DCI) after subarachnoid
hemorrhage can include induced hypertension (iHTN) and, in refractory cases …

被引用次数：9 相关文章所有 7 个版本

[PDF] springer.com

Racial and ethnic differences in restarting antiplatelet therapy in patients with primary intracranial hemorrhage: a systematic review and meta-analysis

X Wang, T Chen, J Zhou, Y Qin - BMC neurology, 2024 - Springer

Background There has long been clinical disagreement over the resumption of antiplatelet
therapy in patients with primary intracranial hemorrhage (ICH). This meta-analysis aimed to …

Cilostazol Alleviates Delayed Cerebral Ischemia after Subarachnoid Hemorrhage by Attenuating Microcirculatory Dysfunction

M Naraoka, N Shimamura, H Ohkuma - 2024 - researchsquare.com

Cilostazol, which exerts its antiplatelet effect by inhibiting anti-PDE3, could have a
therapeutic effect on delayed cerebral ischemia (DCI) after aneurysmal subarachnoid …